Author

Mark Berner-Hansen

ACUTE INTESTINOTROPHIC EFFECTS OF SHORT AND LONG-ACTING GLP-2 ANALOGUES IN RATS
ACUTE INTESTINOTROPHIC EFFECTS OF SHORT AND LONG-ACTING GLP-2 ANALOGUES IN RATS

Mark Berner-Hansen  et al.

GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOGUE, EXPOSURE DOES NOT CORRELATE WITH HEPATIC INDOCYANINE GREEN CLEARANCE
GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOGUE, EXPOSURE DOES NOT CORRELATE WITH HEPATIC INDOCYANINE GREEN CLEARANCE

Mark Berner-Hansen  et al.

NANOMOLAR EP4 RECEPTOR POTENCY IN NORMAL APPEARING COLONIC MUCOSA FROM PATIENTS WITH COLORECTAL NEOPLASIA
NANOMOLAR EP4 RECEPTOR POTENCY IN NORMAL APPEARING COLONIC MUCOSA FROM PATIENTS WITH COLORECTAL NEOPLASIA

Mark Berner-Hansen  et al.

GEOGRAPHIC EVOLUTION OF PEDIATRIC INTESTINAL FAILURE (PIF) MANAGEMENT IN THE UNITED STATES (US)
GEOGRAPHIC EVOLUTION OF PEDIATRIC INTESTINAL FAILURE (PIF) MANAGEMENT IN THE UNITED STATES (US)

Mark Berner-Hansen  et al.

THE NOVEL DUAL GLP-1 AND GLP-2 RECEPTOR AGONIST DAPIGLUTIDE ATTENUATES INTESTINAL INSUFFICIENCY IN A MURINE SHORT BOWEL MODEL
THE NOVEL DUAL GLP-1 AND GLP-2 RECEPTOR AGONIST DAPIGLUTIDE ATTENUATES INTESTINAL INSUFFICIENCY IN A MURINE SHORT BOWEL MODEL

Mark Berner-Hansen  et al.

Item 1 - 5 / 5
1